243 related articles for article (PubMed ID: 12118562)
1. Carcinoma of the uterine cervix. II. Lack of impact of prolongation of overall treatment time on morbidity of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):3-11. PubMed ID: 12118562
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation.
Perez CA; Grigsby PW; Lockett MA; Chao KS; Williamson J
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):855-66. PubMed ID: 10386643
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
[TBL] [Abstract][Full Text] [Related]
4. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison.
Perez CA; Grigsby PW; Camel HM; Galakatos AE; Mutch D; Lockett MA
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):703-16. PubMed ID: 7860381
[TBL] [Abstract][Full Text] [Related]
5. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix.
Perez CA; Grigsby PW; Chao KS; Mutch DG; Lockett MA
Int J Radiat Oncol Biol Phys; 1998 May; 41(2):307-17. PubMed ID: 9607346
[TBL] [Abstract][Full Text] [Related]
6. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
Chen SW; Liang JA; Yang SN; Ko HL; Lin FJ
Radiother Oncol; 2003 Apr; 67(1):69-76. PubMed ID: 12758242
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.
Ferrigno R; Campos de Oliveira Faria SL; Weltman E; Salvajoli JV; Segreto RA; Pastore A; Nadalin W
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):695-706. PubMed ID: 12573757
[TBL] [Abstract][Full Text] [Related]
8. High dose rate brachytherapy for carcinoma of the cervix: risk factors for late rectal complications.
Uno T; Itami J; Aruga M; Kotaka K; Fujimoto H; Sato T; Minoura S; Ito H
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):615-21. PubMed ID: 9486611
[TBL] [Abstract][Full Text] [Related]
9. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
Rogers CL; Freel JH; Speiser BL
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients.
Lorvidhaya V; Tonusin A; Changwiwit W; Chitapanarux I; Srisomboon J; Wanwilairat S; Chawapun N; Sukthomya V
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1185-91. PubMed ID: 10725630
[TBL] [Abstract][Full Text] [Related]
11. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies.
Barillot I; Horiot JC; Maingon P; Truc G; Chaplain G; Comte J; Brenier JP
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):189-200. PubMed ID: 10924989
[TBL] [Abstract][Full Text] [Related]
12. The irradiation tolerance dose of the proximal vagina.
Au SP; Grigsby PW
Radiother Oncol; 2003 Apr; 67(1):77-85. PubMed ID: 12758243
[TBL] [Abstract][Full Text] [Related]
13. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
14. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
Roeske JC; Mundt AJ; Halpern H; Sweeney P; Sutton H; Powers C; Rotmensch J; Waggoner S; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):351-8. PubMed ID: 9069307
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of morbidity after external radiotherapy and intracavitary brachytherapy in 771 patients with carcinoma of the uterine cervix or endometrium.
Yalman D; Arican A; Ozsaran Z; Celik OK; Yürüt V; Esassolak M; Haydaroglu A
Eur J Gynaecol Oncol; 2002; 23(1):58-62. PubMed ID: 11876395
[TBL] [Abstract][Full Text] [Related]
16. Lack of the dose-rate effect of 192Ir source activity on pelvic control and late complications after high-dose-rate brachytherapy for cervical cancer.
Chen SW; Liang JA; Shiau AC; Yu CY; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
J Radiat Res; 2010; 51(2):173-9. PubMed ID: 20339254
[TBL] [Abstract][Full Text] [Related]
17. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods.
Perez CA; Fox S; Lockett MA; Grigsby PW; Camel HM; Galakatos A; Kao MS; Williamson J
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):885-98. PubMed ID: 1917616
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: an audit from India.
Saibishkumar EP; Patel FD; Sharma SC
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):30-7. PubMed ID: 16477917
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme.
Wang CJ; Leung SW; Chen HC; Sun LM; Fang FM; Changchien CC; Huang EY; Wu JM; Chen CC
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):391-8. PubMed ID: 9226328
[TBL] [Abstract][Full Text] [Related]
20. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy.
Chen SW; Liang JA; Yang SN; Liu RT; Lin FJ
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):955-61. PubMed ID: 10863065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
